Pathstone Family Office’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$211K Buy
+1,628
New +$211K ﹤0.01% 1489
2023
Q1
Sell
-1,687
Closed -$269K 1357
2022
Q4
$269K Sell
1,687
-3,551
-68% -$566K ﹤0.01% 1283
2022
Q3
$698K Buy
+5,238
New +$698K 0.01% 921
2014
Q4
Sell
-50
Closed -$8K 173
2014
Q3
$8K Buy
+50
New +$8K 0.02% 232